Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ricklin

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
European Journal of Clinical Investigation|February 14, 2015
Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside interventionDimitrios C Mastellos, Despina Yancopoulou, Petros Kokkinos, et al.
Acta Biomaterialia|November 3, 2022
Complement-regulatory biomaterial coatings: Activity and selectivity profile of the factor H-binding peptide 5C6Clément Bechtler, Sophia Koutsogiannaki, Ekaterina Umnyakova, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2015
Attenuation of Staphylococcus aureus-Induced Bacteremia by Human Mini-Antibodies Targeting the Complement Inhibitory Protein EfbMaria Georgoutsou-Spyridonos, Daniel Ricklin, Haris Pratsinis, et al.
Blood|December 29, 2016
Incomplete inhibition by eculizumab: mechanistic evidence for residual C5 activity during strong complement activationMarkus J Harder, Nadine Kuhn, Hubert Schrezenmeier, et al.
Haematologica|June 8, 2019
Complement C3 inhibition by compstatin Cp40 prevents intra- and extravascular hemolysis of red blood cellsInge Baas, Laura Delvasto-Nuñez, Peter Ligthart, et al.
Journal of Clinical Periodontology|January 6, 2016
Inhibition of pre-existing natural periodontitis in non-human primates by a locally administered peptide inhibitor of complement C3Tomoki Maekawa, Ruel A Briones, Ranillo R G Resuello, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2010
Allosteric inhibition of complement function by a staphylococcal immune evasion proteinHui Chen, Daniel Ricklin, Michal Hammel, et al.
Immunobiology|July 17, 2012
New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic propertiesHongchang Qu, Daniel Ricklin, Hongjun Bai, et al.
Journal of Medicinal Chemistry|May 1, 2026
New Analogs of the Compstatin Family of Clinical Complement Inhibitors with Low Picomolar Target AffinityStephanie A Vogt, Alexander J Lander, Karl Herbine, et al.
Frontiers in Immunology|September 29, 2023
Complement inhibition can decrease the haemostatic response in a microvascular bleeding model at multiple levelsMurielle Golomingi, Jessie Kohler, Christina Lamers, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
European Journal of Clinical Investigation|February 14, 2015
Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside interventionDimitrios C Mastellos, Despina Yancopoulou, Petros Kokkinos, et al.
Acta Biomaterialia|November 3, 2022
Complement-regulatory biomaterial coatings: Activity and selectivity profile of the factor H-binding peptide 5C6Clément Bechtler, Sophia Koutsogiannaki, Ekaterina Umnyakova, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2015
Attenuation of Staphylococcus aureus-Induced Bacteremia by Human Mini-Antibodies Targeting the Complement Inhibitory Protein EfbMaria Georgoutsou-Spyridonos, Daniel Ricklin, Haris Pratsinis, et al.
Blood|December 29, 2016
Incomplete inhibition by eculizumab: mechanistic evidence for residual C5 activity during strong complement activationMarkus J Harder, Nadine Kuhn, Hubert Schrezenmeier, et al.
Haematologica|June 8, 2019
Complement C3 inhibition by compstatin Cp40 prevents intra- and extravascular hemolysis of red blood cellsInge Baas, Laura Delvasto-Nuñez, Peter Ligthart, et al.
Journal of Clinical Periodontology|January 6, 2016
Inhibition of pre-existing natural periodontitis in non-human primates by a locally administered peptide inhibitor of complement C3Tomoki Maekawa, Ruel A Briones, Ranillo R G Resuello, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2010
Allosteric inhibition of complement function by a staphylococcal immune evasion proteinHui Chen, Daniel Ricklin, Michal Hammel, et al.
Immunobiology|July 17, 2012
New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic propertiesHongchang Qu, Daniel Ricklin, Hongjun Bai, et al.
Journal of Medicinal Chemistry|May 1, 2026
New Analogs of the Compstatin Family of Clinical Complement Inhibitors with Low Picomolar Target AffinityStephanie A Vogt, Alexander J Lander, Karl Herbine, et al.
Frontiers in Immunology|September 29, 2023
Complement inhibition can decrease the haemostatic response in a microvascular bleeding model at multiple levelsMurielle Golomingi, Jessie Kohler, Christina Lamers, et al.
Pageof 14